1db5

From Proteopedia

Revision as of 14:24, 12 November 2007 by OCA (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

1db5, resolution 2.80Å

Drag the structure with the mouse to rotate

HUMAN S-PLA2 IN COMPLEX WITH INDOLE 6

Contents

Overview

A lead compound obtained from a high volume human non-pancreatic secretory, phospholipase A2 (hnps-PLA2) screen has been developed into a potent, inhibitor using detailed structural knowledge of inhibitor binding to the, enzyme active site. Four crystal structures of hnps-PLA2 complexed with a, series of increasingly potent indole inhibitors were determined and used, as the structural basis for both understanding this binding and providing, valuable insights for further development. The application of, structure-based drug design has made possible improvements in the binding, of this screening lead to the enzyme by nearly three orders of magnitude., Furthermore, the optimized structure (LY311727) displayed 1,500-fold, selectivity when assayed against porcine pancreatic s-PLA2.

Disease

Known diseases associated with this structure: Colorectal cancer, sporadic OMIM:[172411]

About this Structure

1DB5 is a Single protein structure of sequence from Homo sapiens with CA and 6IN as ligands. Active as Phospholipase A(2), with EC number 3.1.1.4 Full crystallographic information is available from OCA.

Reference

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2., Schevitz RW, Bach NJ, Carlson DG, Chirgadze NY, Clawson DK, Dillard RD, Draheim SE, Hartley LW, Jones ND, Mihelich ED, et al., Nat Struct Biol. 1995 Jun;2(6):458-65. PMID:7664108

Page seeded by OCA on Mon Nov 12 16:30:48 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools